• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.关于与HIV-1 B亚型嗜性转变相关的物理化学和结构修饰
AIDS Res Hum Retroviruses. 2016 Aug;32(8):829-40. doi: 10.1089/AID.2015.0373. Epub 2016 Jun 1.
2
Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.利用HIV-1包膜V3来鉴定X4和R5特异性的反式激活因子(Tat)及长末端重复序列(LTR)序列特征。
Retrovirology. 2016 May 3;13(1):32. doi: 10.1186/s12977-016-0266-9.
3
Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.HIV-1 型 C 亚型 gp41 中的某些氨基酸变化与 gp120(V3) 特定特征相关,可调节共受体的使用。
Virus Res. 2012 Sep;168(1-2):73-83. doi: 10.1016/j.virusres.2012.06.019. Epub 2012 Jun 23.
4
The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization.HIV-1外膜糖蛋白gp120的V3环内的N-连接聚糖g15影响共受体使用、细胞嗜性和中和作用。
Virology. 2002 Dec 5;304(1):70-80. doi: 10.1006/viro.2002.1760.
5
Statistical correlation of nonconservative substitutions of HIV gp41 variable amino acid residues with the R5X4 HIV-1 phenotype.HIV gp41可变氨基酸残基的非保守性替换与R5X4 HIV-1表型的统计相关性。
Virol J. 2016 Feb 16;13:28. doi: 10.1186/s12985-016-0486-6.
6
HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?基于 V3 环序列分析的 HIV-1 共受体使用情况:HAART 后是否优先抑制 CXCR4 病毒?
Immunol Invest. 2011;40(6):597-613. doi: 10.3109/08820139.2011.569673. Epub 2011 Apr 25.
7
Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.X4 嗜性的人类免疫缺陷病毒 1 型 V3 截短株通过不同的分子途径,导致不同的核心受体相互作用和对 CXCR4 拮抗剂的敏感性。
J Virol. 2010 Sep;84(17):8777-89. doi: 10.1128/JVI.00333-10. Epub 2010 Jun 23.
8
Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.天然存在的碱性氨基酸取代在人类免疫缺陷病毒1型E亚型包膜V3环中对病毒共受体使用和细胞嗜性的作用。
J Virol. 1999 Jul;73(7):5520-6. doi: 10.1128/JVI.73.7.5520-5526.1999.
9
Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.HIV-1 B 亚型 gp41 中的某些氨基酸突变与 gp120v₃ 特征有关,这些特征调节了辅助受体的使用。
Retrovirology. 2011 May 12;8:33. doi: 10.1186/1742-4690-8-33.
10
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.HIV-1 感染者血浆中存在具有不同核心受体使用偏好的复制型次要变异体。
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.00193-20.

引用本文的文献

1
HIV-1 subtypes maintain distinctive physicochemical signatures in Nef domains associated with immunoregulation.HIV-1 亚型在与免疫调节相关的 Nef 结构域中保持独特的理化特征。
Infect Genet Evol. 2023 Nov;115:105514. doi: 10.1016/j.meegid.2023.105514. Epub 2023 Oct 11.
2
Brain-specific HIV Nef identified in multiple patients with neurological disease.在多名患有神经疾病的患者中发现了大脑特异性 HIV Nef。
J Neurovirol. 2018 Feb;24(1):1-15. doi: 10.1007/s13365-017-0586-0. Epub 2017 Oct 23.
3
Predicted coreceptor usage at end-stage HIV disease in tissues derived from subjects on antiretroviral therapy with an undetectable plasma viral load.在接受抗逆转录病毒治疗且血浆病毒载量不可检测的受试者来源的组织中,对终末期HIV疾病时共受体使用情况的预测。
Infect Genet Evol. 2017 Jul;51:194-197. doi: 10.1016/j.meegid.2017.04.004. Epub 2017 Apr 6.

本文引用的文献

1
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.对CD4细胞计数低于100个细胞/立方毫米的HIV-1感染者进行抗逆转录病毒治疗,会导致单核细胞活化的不同程度恢复。
J Leukoc Biol. 2016 Jul;100(1):223-31. doi: 10.1189/jlb.5AB0915-406R. Epub 2015 Nov 25.
2
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.在CD4+ T细胞恢复欠佳的个体中,将马拉维若添加至抗逆转录病毒抑制疗法的病毒学和免疫学效应
AIDS. 2015 Oct 23;29(16):2121-9. doi: 10.1097/QAD.0000000000000810.
3
Maraviroc: a review of its use in HIV infection and beyond.马拉维若:对其在HIV感染及其他方面应用的综述。
Drug Des Devel Ther. 2015 Oct 1;9:5447-68. doi: 10.2147/DDDT.S90580. eCollection 2015.
4
X4 Tropic Virus Prediction Is Associated with a Nadir CD4 T-Cell Count below 100 Cells/mm.X4嗜性病毒预测与CD4 T细胞计数最低点低于100个细胞/mm³相关。
Intervirology. 2015;58(3):155-9. doi: 10.1159/000398798. Epub 2015 May 21.
5
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption.治疗中断后,大量反弹/失活的HIV变异体在淋巴组织的多灶性感染中出现。
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1126-34. doi: 10.1073/pnas.1414926112. Epub 2015 Feb 23.
6
Editorial: the monocyte/macrophage in the pathogenesis of AIDS: the next frontier for therapeutic intervention in the CNS and beyond: part I.
Curr HIV Res. 2014;12(2):75-6. doi: 10.2174/1570162x1202140725100102.
7
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.马拉维若治疗免疫反应低下的 HIV-1 阳性患者的强化策略:一项意大利的随机临床试验。
PLoS One. 2013 Nov 14;8(11):e80157. doi: 10.1371/journal.pone.0080157. eCollection 2013.
8
Crystal structure of a soluble cleaved HIV-1 envelope trimer.可溶性 HIV-1 包膜三聚体的晶体结构
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
9
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.高个体内 HIV-1 进化率与 CCR5 至 CXCR4 核心受体转换相关。
Infect Genet Evol. 2013 Oct;19:369-77. doi: 10.1016/j.meegid.2013.05.004. Epub 2013 May 11.
10
COFACTOR: an accurate comparative algorithm for structure-based protein function annotation.共因子:一种基于结构的蛋白质功能注释的准确比较算法。
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W471-7. doi: 10.1093/nar/gks372. Epub 2012 May 8.

关于与HIV-1 B亚型嗜性转变相关的物理化学和结构修饰

On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.

作者信息

Lamers Susanna L, Fogel Gary B, Liu Enoch S, Salemi Marco, McGrath Michael S

机构信息

1 Bioinfoexperts, LLC , Thibodaux, Louisiana.

2 Natural Selection, Inc. , San Diego, California.

出版信息

AIDS Res Hum Retroviruses. 2016 Aug;32(8):829-40. doi: 10.1089/AID.2015.0373. Epub 2016 Jun 1.

DOI:10.1089/AID.2015.0373
PMID:27071630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4971420/
Abstract

HIV-1 enters immune cells via binding the viral envelope to a host cell CD4 receptor, and then a secondary co-receptor, usually CCR5 (R5) or CXCR4 (X4), and some HIV can utilize both co-receptors (R5X4). Although a small set of amino-acid properties such as charge and sequence length applied to HIV-1 envelope V3 loop sequence data can be used to predict co-receptor usage, we sought to expand the fundamental understanding of the physiochemical basis of tropism by analyzing many, perhaps less obvious, amino-acid properties over a diverse array of HIV sequences. We examined 74 amino-acid physicochemical scales over 1,559 V3 loop sequences with biologically tested tropisms downloaded from the Los Alamos HIV sequence database. Linear regressions were then calculated for each feature relative to three tropism transitions (R5→X4; R5→R5X4; R5X4→X4). Independent correlations were rank ordered to determine informative features. A structural analysis of the V3 loop was performed to better interpret these findings relative to HIV tropism states. Similar structural changes are required for R5 and R5X4 to transition to X4, thus suggesting that R5 and R5X4 types are more similar than either phenotype is to X4. Overall, the analysis suggests a continuum of viral tropism that is only partially related to charge; in fact, the analysis suggests that charge modification may be primarily attributed to decreased R5 usage, and further structural changes, particularly those associated with β-sheet structure, are likely required for full X4 usage.

摘要

HIV-1通过将病毒包膜与宿主细胞CD4受体结合,然后再与一种辅助受体结合进入免疫细胞,这种辅助受体通常是CCR5(R5)或CXCR4(X4),一些HIV可以利用这两种辅助受体(R5X4)。尽管应用于HIV-1包膜V3环序列数据的一小部分氨基酸特性(如电荷和序列长度)可用于预测辅助受体的使用情况,但我们试图通过分析众多可能不太明显的氨基酸特性,在各种HIV序列中扩展对嗜性生理化学基础的基本理解。我们研究了从洛斯阿拉莫斯HIV序列数据库下载的1559个具有经生物学测试嗜性的V3环序列上的74种氨基酸物理化学尺度。然后针对每个特征相对于三种嗜性转变(R5→X4;R5→R5X4;R5X4→X4)计算线性回归。对独立相关性进行排序以确定信息性特征。对V3环进行了结构分析,以便相对于HIV嗜性状态更好地解释这些发现。R5和R5X4向X4转变需要类似的结构变化,因此表明R5和R5X4类型比任何一种表型与X4都更相似。总体而言,分析表明病毒嗜性是一个连续体,仅部分与电荷相关;事实上,分析表明电荷修饰可能主要归因于R5使用减少,而完全使用X4可能需要进一步的结构变化,特别是那些与β折叠结构相关的变化。